Artivion Data Breach Class Action Investigation

At Console & Associates, our data breach lawyers are closely examining the recent Artivion Incorporated cybersecurity incident. Following the company's disclosure to the Securities and Exchange Commission (SEC) on December 9, 2024, we are investigating the potential impact of this security breach, which involved the encryption and acquisition of company files.

What Happened?

According to the SEC filing, Artivion discovered unauthorized activity in their network on November 21, 2024. The company reported that the incident involved both the encryption and acquisition of files, though the specific nature and scope of the potentially compromised data remain under investigation.

Upon discovering the security breach, Artivion took immediate action by implementing security protocols and taking portions of their network offline. The company has engaged external cybersecurity experts to assist with the ongoing investigation. At this time, no data breach notification letters have been sent, as the investigation is still determining whether sensitive information was compromised.

Steps To Take If You Were Affected By A Data Breach

1. Monitor all accounts and credit reports closely
2. Consider freezing your credit
3. Look out for phishing attempts using information from the Artivion data breach
4. Change passwords for affected accounts
5. Enable two-factor authentication where possible

For more detailed guidance, explore our “Guide for Victims of a Data Breach” to better understand measures you can take to protect yourself after a data breach.

Artivion Overview

Artivion Incorporated represents a presence in the medical device and biotechnology sector, operating from its headquarters in Kennesaw, Georgia. The company has carved out a unique position in the healthcare industry through its dual focus on medical device manufacturing and human tissue preservation. Their operations encompass several critical areas:

• Design and manufacture of specialized medical devices
• Distribution of cryogenically preserved human tissues
• Development of cardiac and vascular transplant solutions
• Innovation in biotechnology and medical device technology

With a workforce of over 1,500 employees and an annual revenue of approximately $368 million, Artivion demonstrates market presence. The company's listing on the New York Stock Exchange under the ticker symbol "AORT" reflects its position as a publicly traded entity, subject to strict regulatory oversight and transparency requirements.

Artivion Data Breach Victims Have Rights - Don’t Wait to Act

How do you know that you were affected by the Artivion data breach? Usually victims receive a NOTICE OF DATA BREACH in the mail, but the impact of a breach can be felt long before notices are sent to those affected. This can be in the form of fraudulent financial activity and other forms of identity theft.

If you believe you were affected, we encourage you to reach out to our data breach law firm for legal assistance through a no-cost consultation about your situation. We will review your eligibility to file a data breach class action lawsuit and discuss your legal rights and any compensation that may be available to you.

Complete our confidential contact form below and a member of our legal team will be in touch.